Gain Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Gain Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Gain Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -204 %, a 20.3% decline year-over-year.
  • Gain Therapeutics, Inc. annual Return On Equity for 2023 was -193 %, a 175% decline from 2022.
  • Gain Therapeutics, Inc. annual Return On Equity for 2022 was -70.1 %, a 99.6% decline from 2021.
  • Gain Therapeutics, Inc. annual Return On Equity for 2021 was -35.1 %, a 66.6% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -204 -34.4 -20.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -214 -84 -64.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -213 -120 -129% Jan 1, 2024 Mar 31, 2024
Q4 2023 -193 -123 -175% Oct 1, 2023 Dec 31, 2023
Q3 2023 -169 -114 -205% Jul 1, 2023 Sep 30, 2023
Q2 2023 -130 -80.7 -163% Apr 1, 2023 Jun 30, 2023
Q1 2023 -93 -52.6 -130% Jan 1, 2023 Mar 31, 2023
Q4 2022 -70.1 -35 -99.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -55.5 -17.4 -45.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49.5 -15.7 -46.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -40.4 -2.89 -7.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.1 +69.9 +66.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38 Jul 1, 2021 Sep 30, 2021
Q2 2021 -33.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -37.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 -105 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.